Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis

Gut and Liver
Mohamed AzabJi Won Yoo

Abstract

Although proton pump inhibitors (PPIs) have been widely used for the prevention and treatment of stress gastric ulcers in hospital settings, there are concerns that PPIs increase the risk of Clostridium difficile infection (CDI). However, little is known about the risk of CDI following PPI and histamine-2 receptor antagonist (H2RA) use. We evaluated the comparative hospital-acquired CDI occurrence risk associated with the concurrent use of PPIs versus H2RAs. A systematic search of PubMed, MEDLINE/Ovid, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, and Google Scholar through August 19, 2016, identified 12 studies that reported the hospital-acquired CDI occurrence following H2RA and PPI use for the prevention and treatment of stress gastric ulcers. Random-effects pooled odds ratios and 95% confidence intervals were estimated. Heterogeneity was measured using I², and a meta-regression analysis was conducted. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to assess the overall quality of the evidence. A total of 74,132 patients from 12 observational studies were analyzed. Compared to H2RAs, PPIs increased the risk of CDI by 38.6% (pooled odds ratio...Continue Reading

References

Jan 26, 1989·The New England Journal of Medicine·L V McFarlandW E Stamm
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Feb 26, 2000·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Apr 6, 2000·QJM : Monthly Journal of the Association of Physicians·S ShahK Woodhouse
Dec 12, 2001·Critical Care : the Official Journal of the Critical Care Forum·D J CookUNKNOWN Canadian Critical Care Trials Group
Mar 31, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoLee H Harrison
May 6, 2005·Journal of the American Medical Directors Association·Farrah Ibrahim J Al-TureihiHenry Isenberg
Dec 13, 2006·Archives of Internal Medicine·Sophia V KazakovaL Clifford McDonald
May 30, 2007·Archives of Internal Medicine·Erik R DubberkeVictoria J Fraser
Jun 27, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Rebekah R Arthur Grube, D Byron May
Apr 16, 2008·QJM : Monthly Journal of the Association of Physicians·M N ChoudhryH M Ziglam
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
May 12, 2010·Archives of Internal Medicine·Michael D HowellDaniel Talmor
Aug 13, 2011·Pharmacoepidemiology and Drug Safety·Vanessa StevensEdwin Wijngaarden
Aug 16, 2011·Journal of Clinical Epidemiology·Gordon H GuyattHolger J Schünemann
Oct 25, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Abhishek DeshpandeAdrian V Hernandez
Nov 4, 2011·The New England Journal of Medicine·Vivian G LooAndre Dascal
Apr 25, 2012·The American Journal of Gastroenterology·Chun Shing KwokYoon Kong Loke
Jun 20, 2012·The American Journal of Gastroenterology·Sailajah JanarthananMurray N Ehrinpreis
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erik R Dubberke, Margaret A Olsen
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alan N BarkunMarc Bardou
Sep 10, 2013·Mayo Clinic Proceedings·Jeffrey F BarlettaCarrington R Raney
Dec 30, 2014·Critical Care : the Official Journal of the Critical Care Forum·Jeffrey F Barletta, David A Sclar
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald

❮ Previous
Next ❯

Citations

Dec 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Troy WatsonEdward Septimus
Jan 29, 2018·Critical Care : the Official Journal of the Critical Care Forum·Hui-Bin HuangBin Du
Aug 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fanny MathiasPatrice Vanelle
Feb 11, 2020·Digestive Diseases and Sciences·Lars Engstrand, David Y Graham
Jun 11, 2020·Expert Review of Anti-infective Therapy·Dianbin LiuYanxia Wei
Jun 4, 2019·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Jessica S TischendorfNasia Safdar
Jan 16, 2020·Intensive Care Medicine·Massimo AntonelliMaria Sole Vallecoccia
May 3, 2019·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Anthony A SochetThomas A Nakagawa
Mar 13, 2019·World Journal of Emergency Surgery : WJES·Massimo SartelliFausto Catena
Jan 20, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Kristin M D'SilvaEmily G McDonald
Mar 10, 2021·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·Sohair Sayed Abu El-EllaAli Mohamed Selim
Nov 24, 2020·Semergen·G M Saiz LaderaJ N García Pascual

❮ Previous
Next ❯

Software Mentioned

Google Scholar
SPSS
GRADEpro
Comprehensive Meta - Analysis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.